Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Jubilant HollisterStier Sterile Expansion Project Underway

Published: Friday, August 16, 2013
Last Updated: Friday, August 16, 2013
Bookmark and Share
New manufacturing area will expand ampoule manufacturing capacity in Montreal.

Jubilant HollisterStier has announced that the Montreal-based manufacturing facility has completed the first phase of an expansion of their sterile manufacturing capacity, with the addition of a new ampoule filling line utilizing a rigid barrier system.

This expansion of capacity is a continuation of improvements being made to further enhance the site’s sterile manufacturing capabilities.

The new manufacturing area will expand ampoule manufacturing capacity in Montreal by nearly two hundred percent.

In addition, expansions to the sterile areas at Jubilant HollisterStier have been optimized through successful implementation of Lean and Six Sigma initiatives.

The new area is scheduled to be ready for product on September 9th 2013. A significant portion of the expanded capacity has already been allocated to new customer products that will be manufactured at the site.

“We are excited to complete this phase of our optimization strategy in sterile manufacturing. Our site in Montreal will be well positioned to continue offering multiple dosage platforms for our global customers. We have been fortunate to secure several new contracts that will utilize our expanded capacity starting this year” said Jubilant HollisterStier Chief Executive Officer, Marcelo Morales.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

JHS Secures Multi-Million Dollar Contracts to Manufacture Sterile Parenteral Products
Company has secured contracts with four innovator life science companies.
Thursday, February 23, 2012
Scientific News
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos